Teriparatide-Associated Late Hypercalcemia: A Report of Two Cases and Literature Review

特立帕肽 医学 无症状的 维生素D与神经学 甲状旁腺激素 骨质疏松症 骨化三醇 内科学 甲状旁腺功能亢进 骨量减少 维生素D缺乏 钙 胃肠病学 内分泌学 儿科 外科 骨矿物
作者
Jovan Milosavljevic,Asha Thomas
出处
期刊:Journal of Community Hospital Internal Medicine Perspectives [Taylor & Francis]
卷期号:12 (1): 54-58 被引量:6
标识
DOI:10.55729/2000-9666.1010
摘要

Teriparatide, recombinant human parathyroid hormone (1-34), is a safe and usually well-tolerated medication. We describe two cases of late-onset hypercalcemia associated with teriparatide use and report current evidence of hypercalcemia during the treatment with PTH analogs.Case 1 is a 54-year-old man with a history of osteoporosis, previously treated with 6 months of teriparatide, but had not been consistent in taking the medication. Before restarting teriparatide, his serum calcium, PTH and vitamin D were normal. Six months into the treatment, he developed asymptomatic hypercalcemia of 11.2 mg/dL 24 h after the last dose. Repeat serum calcium was normal and treatment was continued. Case 2 is a 75-year old woman with a history of osteopenia and severe scoliosis. Before starting teriparatide, her calcium, PTH and vitamin D were normal. Six months into the treatment, she developed asymptomatic hypercalcemia of 12.5 mg/dL. Teriparatide was held and subsequently her serum calcium normalized.Transient hypercalcemia can occur during treatment with teriparatide and usually resolves within 16 h after administration. Late hypercalcemia, occurring more than 24 h after the dose, is rarely seen. It is usually mild, asymptomatic and rarely occurs repeatedly. Hypercalcemia occurs more often in patients with pre-existing hypercalcemia or vitamin D deficiency. It is rarely a cause of treatment disruption (0.18-4%).Clinicians should be aware of this side effect, especially in patients who may be at risk of complications of hypercalcemia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kk完成签到 ,获得积分10
1秒前
hg0000完成签到,获得积分10
1秒前
3秒前
3秒前
zzzzz完成签到,获得积分10
3秒前
6秒前
7秒前
7秒前
吴彦祖完成签到,获得积分10
7秒前
zyx发布了新的文献求助10
7秒前
补药学习完成签到,获得积分10
7秒前
7秒前
8秒前
8秒前
嗯哼完成签到,获得积分10
8秒前
酷波er的应助被鑫淼采纳,获得30
9秒前
lyq完成签到,获得积分10
10秒前
烙饼发布了新的文献求助30
10秒前
啵啵完成签到,获得积分10
10秒前
12秒前
震动的山柳关注了科研通微信公众号
12秒前
知识就是力量完成签到 ,获得积分10
12秒前
12秒前
Ccccc发布了新的文献求助10
13秒前
辉辉完成签到,获得积分10
14秒前
李爱国的应助被ifast采纳,获得10
15秒前
15秒前
15秒前
16秒前
123完成签到,获得积分10
17秒前
Rbb发布了新的文献求助100
17秒前
17秒前
Hinata发布了新的文献求助10
17秒前
李健的小迷弟的应助被Akirus采纳,获得10
17秒前
顾矜的应助被2AECML采纳,获得30
18秒前
烙饼完成签到,获得积分20
18秒前
18秒前
yuyu发布了新的文献求助20
18秒前
高高的冷玉完成签到,获得积分10
19秒前
无心的蓝完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8168163
求助须知:如何正确求助?哪些是违规求助? 9561243
关于积分的说明 21759855
捐赠科研通 7759477
什么是DOI,文献DOI怎么找? 3429959
关于科研通互助平台的介绍 2553757
邀请新用户注册赠送积分活动 2474496